Skip to main content
S 1566 114th Congress Senate

Cancer Drug Coverage Parity Act of 2015

Official title: A bill to amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral … Show full official titleShow less

Official title: A bill to amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms no less favorable than the coverage provided for anticancer medications administered by a health care provider.

Introduced: August 3, 2015 See on congress.gov
Health CancerDrug therapyHealth care costs and insuranceHealth care coverage and accessPrescription drugs
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 11, 2015
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 11, 2015
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action June 11, 2015

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Cancer Drug Coverage Parity Act of 2015

This bill amends the Public Health Service Act to require a group or individual health plan that covers anticancer medications administered by a health care provider to provide no less favorable coverage for anticancer medications administered by a patient. A plan may apply to patient-administered anticancer medications only the cost-sharing and limitations that apply to anticancer medications administered by a health care provider.

These requirements apply to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with these requirements, health plans may not, for anticancer medications: (1) change or replace benefits to increase out-of-pocket costs; (2) reclassify benefits to increase costs; or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1566: Cancer Drug Coverage Parity Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-S-1566/
MLA
"S. 1566: Cancer Drug Coverage Parity Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-S-1566/.
Bluebook (legal)
S. 1566, 114th Cong. (2026), https://openamerica.io/bill/114-S-1566/.
Markdown link
[S. 1566: Cancer Drug Coverage Parity Act of 2015](https://openamerica.io/bill/114-S-1566/)
Report a problem